CompletedPHASE1, PHASE2NCT04511923

Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury

Studying Acute lung injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University College Hospital Galway
Principal Investigator
John Laffey
Professor of Anaesthesia and Intensive Care Medicine, National University of Ireland, Galway, Ireland
Intervention
Nebulised heparin(drug)
Enrollment
40 enrolled
Eligibility
18 years · All sexes
Timeline
20202022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04511923 on ClinicalTrials.gov

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

See all trials for Acute lung injury

← Back to all trials